We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRC
751
DELISTED
First Republic Bank
FRC
| $8.71M | 0.01% |
100,511
-174,089
| -63% | -$16.5M |
|
752
Sysco
SYY
$39.7B
| $8.66M | 0.01% |
142,655
-5,012
| -3% | -$284K |
|
753
Everest Group
EG
$15.2B
| $8.65M | 0.01% |
39,079
-2,561
| -6% | -$577K |
|
754
Host Hotels & Resorts
HST
$16.8B
| $8.61M | 0.01% |
433,858
+35,560
| +9% | +$697K |
|
|
USDP
755
DELISTED
USD PARTNERS LP
USDP
| $8.49M | 0.01% |
754,515
-5,800
| -0.8% | -$61.6K |
|
756
Royal Gold
RGLD
$17.1B
| $8.42M | 0.01% |
102,575
+1,289
| +1% | +$110K |
|
757
Gray Television
GTN
$407M
| $8.38M | 0.01% |
500,538
+461,141
| +1,170% | +$7.2M |
|
|
JCP
758
DELISTED
J.C. Penney Company, Inc.
JCP
| $8.37M | 0.01% |
2,649,673
+686,308
| +35% | +$2.21M |
|
|
RDFN
759
DELISTED
Redfin
RDFN
| $8.35M | 0.01% |
+266,740
| New | +$6.48M |
|
|
AAT
760
American Assets Trust
AAT
$1.49B
| $8.22M | 0.01% |
215,072
+443
| +0.2% | +$17.4K |
|
761
Agios Pharmaceuticals
AGIO
$2.16B
| $8.13M | 0.01% |
142,283
+124,035
| +680% | +$7.8M |
|
|
CLVS
762
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.02M | 0.01% |
117,931
-330
| -0.3% | -$23.1K |
|
763
Atlassian
TEAM
$22B
| $7.91M | 0.01% |
+173,747
| New | +$8.09M |
|
764
Arch Capital
ACGL
$36.1B
| $7.88M | 0.01% |
+260,325
| New | +$8.32M |
|
|
ICON
765
DELISTED
Iconix Brand Group, Inc.
ICON
| $7.74M | 0.01% |
600,086
-3,626
| -0.6% | -$103K |
|
766
Helen of Troy
HELE
$663M
| $7.56M | 0.01% |
78,441
-50,830
| -39% | -$4.68M |
|
767
Addus HomeCare
ADUS
$2.14B
| $7.55M | 0.01% |
216,984
+5,087
| +2% | +$173K |
|
|
AHGP
768
DELISTED
Alliance Holdings GP
AHGP
| $7.51M | 0.01% |
280,316
-5,600
| -2% | -$148K |
|
769
Arrow Electronics
ARW
$10.9B
| $7.49M | 0.01% |
93,152
+10,706
| +13% | +$860K |
|
770
Kirby Corp
KEX
$7.95B
| $7.43M | 0.01% |
111,270
+17,058
| +18% | +$1.12M |
|
771
Welltower
WELL
$178B
| $7.35M | 0.01% |
115,245
+26,035
| +29% | +$1.75M |
|
772
LendingTree
TREE
$544M
| $7.26M | 0.01% |
21,316
+19,754
| +1,265% | +$5.61M |
|
|
UNIT
773
CALL
Uniti Group
UNIT
$2.63B
| $7.12M | 0.01% |
+400,000
| New | +$6.59M |
|
|
GG
774
DELISTED
Goldcorp Inc
GG
| $7.02M | 0.01% |
550,000
-50,000
| -8% | -$646K |
|
|
FRED
775
DELISTED
Fred's Inc
FRED
| $6.94M | 0.01% |
1,712,312
+64,551
| +4% | +$313K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.